Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Real World Data and Evidence: Support for Drug Approval: Applications to Kidney Diseases.

Thompson AM, Southworth MR.

Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1531-1532. doi: 10.2215/CJN.02790319. Epub 2019 Sep 6. No abstract available.

PMID:
31492691
2.

Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.

Senatore F, Jagadeesh G, Rose M, Pillai VC, Hariharan S, Liu Q, McDowell TY, Sapru MK, Southworth MR, Stockbridge N.

Am J Cardiovasc Drugs. 2019 Apr;19(2):227. doi: 10.1007/s40256-019-00335-7.

PMID:
30820768
3.

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.

Graham DJ, Baro E, Zhang R, Liao J, Wernecke M, Reichman ME, Hu M, Illoh O, Wei Y, Goulding MR, Chillarige Y, Southworth MR, MaCurdy TE, Kelman JA.

Am J Med. 2019 May;132(5):596-604.e11. doi: 10.1016/j.amjmed.2018.12.023. Epub 2019 Jan 9.

PMID:
30639551
4.

FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.

Senatore F, Jagadeesh G, Rose M, Pillai VC, Hariharan S, Liu Q, McDowell TY, Sapru MK, Southworth MR, Stockbridge N.

Am J Cardiovasc Drugs. 2019 Feb;19(1):11-20. doi: 10.1007/s40256-018-0297-9. Erratum in: Am J Cardiovasc Drugs. 2019 Apr;19(2):227.

PMID:
30144016
5.

Relationship between International Normalized Ratio and Outcomes in Modern Trials with Warfarin Controls.

McDowell TY, Lawrence J, Florian J, Southworth MR, Grant S, Stockbridge N.

Pharmacotherapy. 2018 Sep;38(9):899-906. doi: 10.1002/phar.2161. Epub 2018 Jul 16.

PMID:
29920722
6.

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.

Scott PE, Unger EF, Jenkins MR, Southworth MR, McDowell TY, Geller RJ, Elahi M, Temple RJ, Woodcock J.

J Am Coll Cardiol. 2018 May 8;71(18):1960-1969. doi: 10.1016/j.jacc.2018.02.070.

7.

Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.

Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10.

PMID:
29318683
8.

Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.

Go AS, Singer DE, Toh S, Cheetham TC, Reichman ME, Graham DJ, Southworth MR, Zhang R, Izem R, Goulding MR, Houstoun M, Mott K, Sung SH, Gagne JJ.

Ann Intern Med. 2017 Dec 19;167(12):845-854. doi: 10.7326/M16-1157. Epub 2017 Nov 14. Erratum in: Ann Intern Med. 2018 Aug 7;169(3):204.

PMID:
29132153
9.

Antihypertensive drug associated angioedema: effect modification by race/ethnicity.

Reichman ME, Wernecke M, Graham DJ, Liao J, Yap J, Chillarige Y, Southworth MR, Keeton S, Goulding MR, Mott K, Kelman JA.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1190-1196. doi: 10.1002/pds.4260. Epub 2017 Jul 19.

PMID:
28722207
10.

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.

Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA.

JAMA Intern Med. 2016 Nov 1;176(11):1662-1671. doi: 10.1001/jamainternmed.2016.5954. Erratum in: JAMA Intern Med. 2016 Nov 1;176(11):1729.

PMID:
27695821
11.

Electronic health records to facilitate clinical research.

Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, Goldman S, Janmohamed S, Kreuzer J, Leenay M, Michel A, Ong S, Pell JP, Southworth MR, Stough WG, Thoenes M, Zannad F, Zalewski A.

Clin Res Cardiol. 2017 Jan;106(1):1-9. doi: 10.1007/s00392-016-1025-6. Epub 2016 Aug 24. Review.

12.

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.

Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.

Circulation. 2015 Jan 13;131(2):157-64. doi: 10.1161/CIRCULATIONAHA.114.012061. Epub 2014 Oct 30.

PMID:
25359164
13.

Just Say No?

Southworth MR, Stockbridge N.

Ther Innov Regul Sci. 2014 Sep;48(5):552-553. doi: 10.1177/2168479014528340. No abstract available.

PMID:
30231448
14.

Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it means.

Hariharan S, Southworth MR, Madabushi R.

J Clin Pharmacol. 2014 Aug;54(8):884-8. doi: 10.1002/jcph.337. No abstract available.

PMID:
25044100
15.

Dabigatran and postmarketing reports of bleeding.

Southworth MR, Reichman ME, Unger EF.

N Engl J Med. 2013 Apr 4;368(14):1272-4. doi: 10.1056/NEJMp1302834. Epub 2013 Mar 13. No abstract available.

PMID:
23484796
16.

Interaction of clopidogrel and omeprazole.

Southworth MR, Temple R.

N Engl J Med. 2010 Nov 11;363(20):1977. doi: 10.1056/NEJMc1012022. No abstract available.

PMID:
21067412
17.

Nonbenzodiazepine hypnotic use and cases of "sleep driving".

Southworth MR, Kortepeter C, Hughes A.

Ann Intern Med. 2008 Mar 18;148(6):486-7. No abstract available.

PMID:
18347361
18.

New treatment option for heart failure patients: eplerenone.

Southworth MR, Cavallari LH.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):390-5. Review.

PMID:
15529060
19.

Racial differences in patients' potassium concentrations during spironolactone therapy for heart failure.

Cavallari LH, Fashingbauer LA, Beitelshees AL, Groo VL, Southworth MR, Viana MA, Williams RE, Dunlap SH.

Pharmacotherapy. 2004 Jun;24(6):750-6.

PMID:
15222665
20.

Guidelines for acute decompensated heart failure treatment.

DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT.

Ann Pharmacother. 2004 Apr;38(4):649-60. Epub 2004 Feb 24. Review. Erratum in: Ann Pharmacother. 2004 Jun;38(6):1092.

PMID:
14982975
21.

Treatment options for acute decompensated heart failure.

Southworth MR.

Am J Health Syst Pharm. 2003 Aug 15;60 Suppl 4:S7-15. Review.

PMID:
12966901
22.
23.

Comparison of sotalol versus quinidine for maintenance of normal sinus rhythm in patients with chronic atrial fibrillation.

Southworth MR, Zarembski D, Viana M, Bauman J.

Am J Cardiol. 1999 Jun 15;83(12):1629-32.

PMID:
10392866
24.

The use of HMG-CoA reductase inhibitors to prevent accelerated graft atherosclerosis in heart transplant patients.

Southworth MR, Mauro VF.

Ann Pharmacother. 1997 Apr;31(4):489-91. Review.

PMID:
9101013

Supplemental Content

Loading ...
Support Center